Brian J. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brian J. Miller has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Peter Buckley
5 shared publicationsAndrew Mellor
Immunotherapy Center, Georgia Health Sciences University, Augusta, Georgia, US
3 shared publicationsBrian Kirkpatrick
Department of Psychiatry and Behavioral Science, Texas A&M University y Scott and White Hospital, Temple, Texas, Estados Unidos
3 shared publicationsPeter F. Buckley
2 shared publicationsWesley Seabolt
Department of Psychiatry and Health Behavior, Georgia Health Sciences University, Augusta, Georgia, Estados Unidos
2 shared publicationsAntti Tanskanen
Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland
1 shared publication
Latest Publications
- 1 April 2014
- Published by Elsevier in Schizophrenia Research
- Vol. 153, S347
Poster #T161 AN OPEN-LABEL TRIAL OF ADJUNCTIVE TOCILIZUMAB IN SCHIZOPHRENIA
- 1 April 2014
- Published by Elsevier in Schizophrenia Research
- Vol. 153, S347
Poster #T161 AN OPEN-LABEL TRIAL OF ADJUNCTIVE TOCILIZUMAB IN SCHIZOPHRENIA
- 1 April 2013
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 42, 92-100
Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies
- 1 April 2013
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 42, 92-100
Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies
- 15 March 2013
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 74 (03) , 271-277
A Prevalence Study of Urinary Tract Infections in Acute Relapse of Schizophrenia
Schizophrenia is associated with immune abnormalities and increased mortality from infectious diseases. The aim of this study was to examine whether acute relapse of schizophrenia was associated with urinary tract infection (UTI), in comparison with controls, after controlling for potential confounding factors. In a prevalence study conducted from January 2010 to April 2012 at Georgia Health Sciences University Medical Center, Augusta, we recruited 136 adult subjects (mean age = 42.8 years): 57 inpatients with an acute relapse of DSM-IV schizophrenia, 40 stable outpatients with DSM-IV schizophrenia, and 39 healthy controls from the community. Urinary tract infection was defined as having positive leukocyte esterase and/or positive nitrites on urinalysis and having ≥ 5 leukocytes per high-powered field (implies 5-10 or more) on urine microscopy. Determination of UTI status was made for each subject, and analyses were performed to examine the association between UTI and acute relapse of schizophrenia. 35% of acutely relapsed subjects, versus 5% of stable outpatients and 3% of controls, had a UTI (P < .001). Only 40% of subjects in the acute relapse group classified as having a UTI were treated with antibiotics during hospitalization. After analyses were controlled for gender and smoking status, subjects in the acute relapse group were almost 29 times more likely to have a UTI than controls (odds ratio = 28.97; 95% CI, 3.44-243.85; P = .002). There was no statistically significant association with UTI among the stable outpatients versus controls. Our finding of an association between an increased prevalence of UTI and acute psychotic relapse warrants replication in other samples. The mechanism of this association remains unclear. The results also highlight the potential importance of monitoring for comorbid UTI in acutely relapsed patients with schizophrenia.
- 15 March 2013
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 74 (03) , 271-277
A Prevalence Study of Urinary Tract Infections in Acute Relapse of Schizophrenia
Schizophrenia is associated with immune abnormalities and increased mortality from infectious diseases. The aim of this study was to examine whether acute relapse of schizophrenia was associated with urinary tract infection (UTI), in comparison with controls, after controlling for potential confounding factors. In a prevalence study conducted from January 2010 to April 2012 at Georgia Health Sciences University Medical Center, Augusta, we recruited 136 adult subjects (mean age = 42.8 years): 57 inpatients with an acute relapse of DSM-IV schizophrenia, 40 stable outpatients with DSM-IV schizophrenia, and 39 healthy controls from the community. Urinary tract infection was defined as having positive leukocyte esterase and/or positive nitrites on urinalysis and having ≥ 5 leukocytes per high-powered field (implies 5-10 or more) on urine microscopy. Determination of UTI status was made for each subject, and analyses were performed to examine the association between UTI and acute relapse of schizophrenia. 35% of acutely relapsed subjects, versus 5% of stable outpatients and 3% of controls, had a UTI (P < .001). Only 40% of subjects in the acute relapse group classified as having a UTI were treated with antibiotics during hospitalization. After analyses were controlled for gender and smoking status, subjects in the acute relapse group were almost 29 times more likely to have a UTI than controls (odds ratio = 28.97; 95% CI, 3.44-243.85; P = .002). There was no statistically significant association with UTI among the stable outpatients versus controls. Our finding of an association between an increased prevalence of UTI and acute psychotic relapse warrants replication in other samples. The mechanism of this association remains unclear. The results also highlight the potential importance of monitoring for comorbid UTI in acutely relapsed patients with schizophrenia.
- 1 April 2012
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 10 (2) , 115-123
Is Relapse in Schizophrenia an Immune-Mediated Effect?
- 1 April 2012
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 10 (2) , 115-123
Is Relapse in Schizophrenia an Immune-Mediated Effect?
- 31 December 2011
- Published by Elsevier in Psiquiatría Biológica
- Vol. 18 (4) , 127-136
Metaanálisis de los estudios publicados sobre alteraciones de los valores de las citocinas en la esquizofrenia: efectos del estado clínico y de los antipsicóticos
- 31 December 2011
- Published by Elsevier in Psiquiatría Biológica
- Vol. 18 (4) , 127-136
Metaanálisis de los estudios publicados sobre alteraciones de los valores de las citocinas en la esquizofrenia: efectos del estado clínico y de los antipsicóticos
- Top Cited Papers
- 1 October 2011
- Published by Elsevier in Biological Psychiatry
- Vol. 70 (7) , 663-671
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- 1 October 2011
- Published by Elsevier in Biological Psychiatry
- Vol. 70 (7) , 663-671
Top Cited PapersMeta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- 19 September 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 133 (1-3) , 125-132
Advanced paternal age and parental history of schizophrenia
- 19 September 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 133 (1-3) , 125-132
Advanced paternal age and parental history of schizophrenia